Infringement Analysis in San Diego.

A patent infringement analysis San Diego litigators can rely on has to speak two very different technical languages at once, because the city sits at the intersection of the world’s densest wireless-standards cluster and one of its largest life-science hubs. San Diego is the home of Qualcomm, the global standard-essential-patent (SEP) and FRAND powerhouse behind CDMA, LTE and 5G, and the base of a semiconductor, Wi-Fi and cellular R&D ecosystem few regions can match. It is, in the same breath, a top-tier biotech and genomics capital on the Torrey Pines mesa, anchored by UC San Diego, Illumina and a wall of pharma and med-device companies. Every dispute here still turns on one question: does the accused product actually practise the claim? PerspireIP builds the claim charts and evidence-of-use that answer it, scoped to the forum where the case will be tried.

Where a patent infringement analysis San Diego case is decided

A patent-infringement suit arising in San Diego is filed in the U.S. District Court for the Southern District of California (S.D. Cal.), the federal trial court that has hosted some of the era’s largest technology cases — including the Qualcomm and Apple litigation tried downtown. It is a court of general federal jurisdiction with juries, broad discovery and a patent local-rules practice, so a case is proven through infringement contentions, expert reports and document production rather than a single court-appointed expert. Building evidence to that standard from the outset is the first strategic decision in any San Diego matter.

Venue is not automatic. Under the Supreme Court’s TC Heartland decision a defendant may be sued only where it resides — its state of incorporation — or where it has committed acts of infringement and maintains a regular and established place of business. Because so many wireless and life-science companies are headquartered or have real R&D facilities in the region, S.D. Cal. is frequently a proper and strategically attractive home court. Getting the venue theory right, and tying it to the accused activity, is part of the analysis long before trial.

• U.S. District Court, S.D. Cal. — the federal trial forum for infringement and damages, with juries, discovery and patent local rules
• PTAB (USPTO) — inter partes review, the parallel administrative track where an accused party challenges patent validity
• U.S. International Trade Commission (ITC) — Section 337 investigations that can exclude infringing imports at the border, a favourite of SEP and electronics disputes
• U.S. Court of Appeals for the Federal Circuit — the single appellate court that reviews district-court, PTAB and ITC patent decisions nationwide

The multi-forum reality shapes the deliverable. An accused chipmaker may face a district-court complaint, an ITC exclusion request and an inter partes review at the PTAB in parallel, each with its own timetable and standard of proof. A claim chart built once, rigorously and to the evidence, travels across all three — which is exactly why a disciplined analysis pays for itself early.

Wireless, SEP and FRAND claim charts for a chipset case

San Diego is a wireless-technology capital, and that writes the first half of its infringement docket. Qualcomm is headquartered here, a global leader in standard-essential patents covering CDMA, LTE and 5G, and the region is thick with cellular, Wi-Fi and semiconductor R&D. A standard-essential-patent dispute is unlike an ordinary one: the patentee has declared its patent essential to a technical standard and committed to license it on FRAND (fair, reasonable and non-discriminatory) terms, so the fight runs on two fronts at once — essentiality and infringement on one side, licensing and damages on the other.

The analytical core is an essentiality and infringement claim chart that maps the asserted claim, element by element, onto the specific clause of the cellular standard (a 3GPP technical specification, for example) and then onto the accused chipset or handset that implements it. Where a patent is genuinely essential, practising the standard is practising the claim — but that link has to be proven, not assumed, because many declared-essential patents are over-declared and do not in fact read on the mandatory portions of the standard.

• Standard-to-claim mapping that ties each limitation to a mandatory clause of the cellular or Wi-Fi standard, distinguishing essential from merely optional features
• Chipset and device evidence-of-use built from teardowns, register-level and firmware analysis, conformance data and public technical documentation
• Essentiality checks that separate a truly standard-essential patent from an over-declared one that the accused product can practise around
• Non-infringement and FRAND-defence support for an accused implementer, framing the licensing and damages story alongside the technical read

This is also why the ITC looms so large for local electronics cases: an imported chipset or device that infringes can be barred at the border under Section 337, giving the patentee enormous leverage. A patent infringement analysis San Diego electronics companies commission therefore has to be trial-grade and portable — strong enough for a jury, an administrative-law judge and a PTAB panel alike.

Life-science and biotech charts on the Torrey Pines mesa

The other half of San Diego’s docket is written by the life sciences. The Torrey Pines mesa and the La Jolla research corridor pack UC San Diego, the Salk Institute, Scripps Research and Sanford Burnham Prebys alongside Illumina and a global cluster of genomics, sequencing, pharmaceutical and medical-device companies. The patents asserted here read on small molecules, biologics, antibodies, diagnostic assays, sequencing chemistry and device design — and the way infringement is proven looks nothing like a chipset teardown.

Pharmaceutical disputes often arrive through the Hatch-Waxman framework, where a generic company’s abbreviated new drug application (ANDA) with a Paragraph IV certification is itself a statutory act of infringement, triggering suit before the branded patents expire. Biologics run the parallel BPCIA “patent dance.” In both, infringement turns on chemistry and formulation rather than declared standards, so the claim chart is built from the generic’s own regulatory filing, the drug’s composition, and comparative laboratory and analytical evidence.

• Small-molecule and formulation charts read against an ANDA product’s composition, salt form, polymorph and manufacturing route, with doctrine-of-equivalents analysis where literal infringement is contested
• Biologic and antibody charts mapping sequence, structure and function to the asserted claim under the BPCIA
• Diagnostic, genomics and sequencing charts grounded in assay chemistry, instrument behaviour and protocol evidence
• Med-device charts built from teardowns, engineering drawings and clinical or bench-test data

Because these cases live and die on laboratory and analytical proof, the evidence-of-use has to be dated, reproducible and defensible under cross-examination. A San Diego life-science chart is a scientific document as much as a legal one — which is precisely the work PerspireIP is built to do.

Two analysis modes, one rigorous method

The value of a specialist analysis in San Diego is that the same discipline serves two very different technologies without cutting corners on either. A wireless-SEP chart is an exercise in standards reading — parsing a 3GPP specification, isolating the mandatory clauses, and proving that the accused chipset implements them exactly as the claim requires. A life-science chart is an exercise in scientific evidence — comparing compositions, sequences and assay behaviour and reconstructing what the accused product actually is from regulatory filings and laboratory work.

What unites them is claim construction. Every chart starts from a defensible construction fixed against the claims, the specification and the prosecution history, because a limitation read too broadly collapses at trial and one read too narrowly surrenders infringement. From that anchor we map each element to the accused product — literally where the evidence supports it, and under the doctrine of equivalents where it does not — and we hold non-infringement and invalidity theories in view for the party defending the case.

The analysis cuts both ways. For a patentee it converts a suspicion into a chart a jury, an ITC judge or a PTAB panel can adopt. For an accused chipmaker, generic filer or device company it builds the non-infringement read that keeps a product on the market and frames the invalidity case that runs in parallel at the PTAB. Either way the decisive input is a rigorous, evidence-backed chart — never a conclusion asserted without proof.

How PerspireIP builds a San Diego infringement-analysis file

Every engagement follows the same disciplined path. We construct claim scope first, fixing the correct construction from the claims, specification and prosecution history, then map each element against the real accused product. For wireless and semiconductor matters we work from standards analysis, teardowns, register- and firmware-level evidence and conformance data; for life sciences we work from regulatory filings, compositions, sequences and comparative laboratory results — charting infringement literally and, where appropriate, under the doctrine of equivalents.

• Claim construction and element-by-element charting for a U.S. patent, scoped to S.D. Cal. patent local rules and infringement contentions
• SEP essentiality and FRAND-context mapping for cellular, Wi-Fi and chipset disputes, portable to an ITC Section 337 filing
• Hatch-Waxman/ANDA and BPCIA evidence-of-use built from regulatory filings, formulation data and laboratory analysis
• Non-infringement and invalidity positioning coordinated with a parallel PTAB inter partes review
• Deliverables ready for a district-court complaint, an expert report, or a Federal Circuit appeal record

We work alongside your trial counsel as a specialist analysis partner, deliver to court and PTAB deadlines, and keep every engagement confidential. Whether you are a wireless or semiconductor company enforcing an SEP, a branded or generic pharma facing a Hatch-Waxman dispute, a genomics or device innovator, or the accused party clearing a path to market, we scale to fit — a single claim chart, a multi-patent matter or ongoing portfolio support. Send us the patent number and the accused product, and we will scope a patent infringement analysis San Diego project within one business day.

IP Landscape & Resources in San Diego

Key intellectual-property authorities and venues relevant to San Diego:

• United States Patent and Trademark Office (USPTO) — the federal agency that grants U.S. patents and, through the Patent Trial and Appeal Board (PTAB), hears inter partes reviews challenging patent validity in parallel with district-court litigation
• U.S. District Court for the Southern District of California — the federal trial court that hears San Diego patent-infringement suits under its patent local rules, with juries, discovery and infringement contentions
• U.S. International Trade Commission (ITC) — conducts Section 337 investigations that can exclude infringing imported chipsets and devices at the border, a powerful parallel forum for San Diego electronics and SEP disputes
• U.S. Court of Appeals for the Federal Circuit — the single appellate court with nationwide jurisdiction over patent appeals from the district courts, the PTAB and the ITC

Request a Patent Infringement Analysis in San Diego

Explore related PerspireIP services: Patent Infringement Analysis · Prior Art Litigation Search · Patent Invalidation.

Frequently Asked Questions